Meghmani Organics: Certified Copy of the order passed by the NCLT Ahmedabad Bench
Meghmani Organics (MOL) filed a disclosure titled "Certified Copy of the order passed by the NCLT Ahmedabad Bench". The company is valued at about ₹1,468 crore.
What happened
Meghmani Organics (MOL) filed a disclosure with the exchanges on 9 October 2026 at 06:13 PM titled "Certified Copy of the order passed by the NCLT Ahmedabad Bench".
Company snapshot
Meghmani Organics is a small-cap company, with a market value of about ₹1,468 crore.
The stock last traded at ₹57.74, against a 52-week range of ₹36.5–₹83.45 (30.8% below the high).
Before this filing the shares had moved −9.1% over the month and +18.3% over three months. Average daily turnover over the last 20 sessions was about ₹4.57 crore.
Promoters held 48.95% at the end of Q1 FY27. Foreign institutions owned 0.91% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 614 | 12.7 | 0.5 |
| Q2 FY26 | 577 | 11.6 | 0.45 |
| Q3 FY26 | 509 | -3.5 | -0.14 |
| Q4 FY26 | 474 | 8 | 0.32 |
| Q1 FY27 | 543 | 48.2 | 1.9 |
What history shows
This is not the company's first m&a disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Market-wide, 2,013 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
In the news
Recent coverage elsewhere (links open the original publisher):
- Meghmani Organics shareholders approve merger of subsidiaries
- Building a resilient, sustainable future in crop protection and pigment solutions: Ankit Patel, CMD, Meghmani Organics
- Meghmani Organics vs Nifty 50: Share Price Performance Compared
- NCLT approves Kilburn Chemicals, Meghmani Crop merger with Meghmani Organics
- Meghmani Organics MOL Trading Window Closed Q2 FY27
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.